Although the sensitivity of the method for Stx2 is lower with respect to Stx1, the herein reported detection of the activity of Stx2 in patients’ sera represents a clear-cut demonstration that this HUS-associated toxin type is operative during STEC infections in humans, despite the presence of blood protecting factors, such as HuSAP. Here, STX2 is linked to hemolytic-uremic syndrome.